ABSTRACT
BACKGROUND: Risk of encapsulating peritoneal sclerosis (EPS) is strongly associated with the duration of peritoneal dialysis (PD), such that patients who have been on PD for some time may consider elective transfer to haemodialysis to mitigate the risk of EPS. There is a need to determine this risk to better inform clinical decision making, but previous studies have not allowed for the competing risk of death. METHODS: This study included new adult PD patients in Australia and New Zealand (ANZ; 1990-2010) or Scotland (2000-08) followed until 2012. Age, time on PD, primary renal disease, gender, data set and diabetic status were evaluated as predictors at the start of PD, then at 3 and 5 years after starting PD using flexible parametric competing risks models. RESULTS: In 17 396 patients (16 162 ANZ, 1234 Scotland), EPS was observed in 99 (0.57%) patients, less frequently in ANZ patients (n = 65; 0.4%) than in Scottish patients (n = 34; 2.8%). The estimated risk of EPS was much lower when the competing risk of death was taken into account (1 Kaplan-Meier = 0.0126, cumulative incidence function = 0.0054). Strong predictors of EPS included age, primary renal disease and time on PD. The risk of EPS was reasonably discriminated at the start of PD (C-statistic = 0.74-0.79) and this improved at 3 and 5 years after starting PD (C-statistic = 0.81-0.92). CONCLUSIONS: EPS risk estimates are lower when calculated using competing risk of death analyses. A patient's estimated risk of EPS is country-specific and can be predicted using age, primary renal disease and duration of PD.
Subject(s)
Peritoneal Dialysis/adverse effects , Peritoneal Diseases/etiology , Peritoneal Diseases/mortality , Risk Assessment/methods , Sclerosis/etiology , Sclerosis/mortality , Adult , Aged , Female , Humans , Male , Middle Aged , New Zealand , Peritoneal Diseases/pathology , Prognosis , Risk Factors , Sclerosis/pathology , Scotland , Survival RateABSTRACT
Gas-bubble disease occurs in aquatic species that are exposed to water that is supersaturated with gases. In February 2007, municipal water supersaturated with gas was inadvertently pumped into the vivarium's aquatic housing systems and affected approximately 450 adult female Xenopus laevis. The inflow of supersaturated water was stopped immediately, the holding tanks aggressively aerated, and all experimental manipulations and feeding ceased. Within the first 6 h after the event, morbidity approached 90%, and mortality reached 3.5%. Acutely affected frogs showed clinical signs of gas-bubble disease: buoyancy problems, micro- and macroscopic bubbles in the foot webbing, hyperemia in foot webbing and leg skin, and loss of the mucous slime coat. All of the frogs that died or were euthanized had areas of mesenteric infarction, which resulted in intestinal epithelial necrosis and degeneration of the muscular tunic. Over the subsequent 2 wk, as gas saturation levels returned to normal, the clinical symptoms resolved completely in the remaining frogs. However, 3 mo later, 85% of them failed to lay eggs or produce oocytes, and the remaining 15% produced oocytes of low number and poor quality, yielding cytosolic extracts with poor to no enzymatic activity. Histology of the egg mass from a single 2- to 3-y-old frog at 3 mo after disease resolution revealed irregularly shaped oocytes, few large mature oocytes, and numerous small, degenerating oocytes. At 6 mo after the incident, the remaining frogs continued to fail to produce eggs of sufficient quantity or quality after hormonal priming. The researchers consequently opted to cull the remainder of the colony and repopulate with new frogs.
Subject(s)
Embolism, Air/veterinary , Hyperoxia/veterinary , Infarction/veterinary , Mesentery/blood supply , Peritoneal Diseases/veterinary , Xenopus laevis/blood , Acute Disease , Animals , Female , Infarction/mortality , Oxidative Stress , Peritoneal Diseases/mortality , Water SupplyABSTRACT
Gliomatosis peritonei (GP) is commonly associated with ovarian teratoma and is not thought to have an adverse prognostic effect. However, the prognostic impact and characteristics of GP remain to be clarified. In this study, we investigated the clinicopathologic features of ovarian teratoma associated with GP, and we further compared ovarian immature teratoma (IT) with GP to ovarian IT without GP. During the study period, there were a total of 16 ovarian teratomas associated with GP. Among them, 15 cases were ovarian ITs of various grades. When ovarian IT with GP (n = 15) was compared to ovarian IT without GP (n = 27), it was found that ovarian IT patients with GP had larger tumor size (median, 19 vs. 13 cm; P < 0.001), more frequent recurrence (40 %, 6/15 vs. 3.7 %, 1/27; P = 0.005), and frequently elevated preoperative CA-125 level (100 %, 12/12 vs. 50 %, 10/20; P = 0.004). All recurrences occurred within 2 years of the initial surgery. Survival curves indicated that ovarian IT patients with GP had significantly shorter recurrence-free survival compared to those without GP (P = 0.002). The 2-year recurrence-free survival rates were 59.3 and 96.3 % in IT with GP and IT without GP, respectively. However, all but one case of IT with GP are currently alive. In conclusion, GP is an adverse prognostic factor characterized by frequent recurrence in patients with ovarian IT.
Subject(s)
Gliosis/pathology , Neoplasm Recurrence, Local , Ovarian Neoplasms/pathology , Peritoneal Diseases/pathology , Teratoma/pathology , Adolescent , Adult , Child , Child, Preschool , Combined Modality Therapy , Female , Gliosis/complications , Gliosis/mortality , Gliosis/therapy , Humans , Ovarian Neoplasms/mortality , Ovarian Neoplasms/therapy , Peritoneal Diseases/complications , Peritoneal Diseases/mortality , Peritoneal Diseases/therapy , Republic of Korea/epidemiology , Survival Rate , Teratoma/mortality , Teratoma/therapy , Young AdultABSTRACT
BACKGROUND: Peritoneal hydatid disease is a rare and poorly known disease. We report our experience with 17 patients treated for peritoneal echinococcosis. The main objectives were to analyze and discuss the specific features of the anatomic peritoneal lesions along with their surgical treatment. METHODS: We analyzed retrospectively all patients treated in our unit for peritoneal echinococcosis between January 2001 and December 2008. Preoperative description of the lesions, and the surgical procedures were carefully reported. RESULTS: Peritoneal hydatidosis represented 6.3% of all abdominal localizations. There were 10 women (58.8%) and 7 men (41.2%). Median age was 34 years. Ten patients (58.8%) had had previous surgery for abdominal echinococcosis. Ten patients (58.8%) had synchronous abdominal localization of hydatid disease, and two patients had synchronous pulmonary localization. Sixteen patients were operated on by laparotomy. We classified the anatomic lesions into four groups: localized form (n = 6, 37.4%), disseminated form (n = 8, 50%), "hydatid carcinomatosis" (n = 3, 18.7%), hydatidoperitoneum (n = 1, 6.25%). One patient had a ruptured hydatid cyst of the left liver. We performed total cystectomies in 10 patients, partial cystectomies in 8 patients, and omentectomy in 5 patients. Two patients (12.5%) had surgical complications. One patient (6.25%) died owing to a pulmonary embolism. Anthelmintic chemotherapy was given to two patients before surgery and to nine patients postoperatively. Recurrences were seen in two patients (14.2%). CONCLUSIONS: Peritoneal echinococcosis can cause a large variety of specific and complex anatomic lesions. The disseminated form is the most common, and therefore the surgical treatment is challenging in most cases.
Subject(s)
Echinococcosis , Omentum/surgery , Peritoneal Diseases , Adult , Anthelmintics/therapeutic use , Combined Modality Therapy , Echinococcosis/diagnosis , Echinococcosis/drug therapy , Echinococcosis/mortality , Echinococcosis/surgery , Female , Follow-Up Studies , Humans , Male , Omentum/pathology , Peritoneal Diseases/diagnosis , Peritoneal Diseases/drug therapy , Peritoneal Diseases/mortality , Peritoneal Diseases/surgery , Postoperative Complications , Retrospective Studies , Treatment OutcomeABSTRACT
OBJECTIVE: To report the outcomes associated with endovascular therapy for patients with chronic mesenteric ischemia (CMI). METHODS: A retrospective review of patients who underwent endovascular therapy for CMI between April 1981 and September 2009 at a single institution was performed. Procedural details, mesenteric arteries treated, technical and clinical success rates, outcomes per patient and per vessel were assessed. RESULTS: In 166 patients treatment was attempted using a variety of balloon and stent platforms during the 28-year period. The technical success rate was 97% per patient and 94% per vessel. The technical success rate of stenting (99.4%) was higher than for percutaneous transluminal angioplasty (PTA; 86%; P = 0.0001). Immediate clinical improvement was seen in 146 out of 166 (88.2%). The type of guidewire or device platform, brachial vs. femoral artery access, balloon and/or stent diameters used, and stenosis vs. occlusion had no statistical impact on mortality or the primary patency of any mesenteric artery outcomes. The outcome of the superior mesenteric artery (SMA) with PTA appears to be superior to that of stenting (P = 0.014). CONCLUSION: Technical success rates are improved with the use of stents; however, PTA use in the SMA seems to offer better primary patency rates. KEY POINTS: ⢠Superior mesenteric artery (SMA) stenosis is often responsible for ischaemic symptoms. ⢠Treatment with percutaneous transluminal angioplasty (PTA) seems superior to stenting ⢠Although technical success rates are improved with the use of stents. ⢠Higher mortality in the elderly and those presenting with nausea/vomiting/bloody stools.
Subject(s)
Endovascular Procedures/mortality , Ischemia/mortality , Ischemia/surgery , Mesentery/blood supply , Peritoneal Diseases/mortality , Peritoneal Diseases/surgery , Adult , Aged , Aged, 80 and over , Chronic Disease , Female , Humans , Ischemia/diagnostic imaging , Male , Mesentery/diagnostic imaging , Mesentery/surgery , Middle Aged , Peritoneal Diseases/diagnostic imaging , Prevalence , Radiography , Risk Assessment , Risk Factors , Survival Analysis , Survival Rate , Treatment Outcome , Virginia/epidemiologyABSTRACT
Canine peritoneal larval cestodiasis (CPLC) is a poorly understood disease of dogs caused by asexual multiplication of larval Mesocestoides spp. tapeworms. In this study, we examined the descriptive statistics and survival characteristics of 60 dogs diagnosed with CPLC from 1989 to 2009. Clinically affected dogs presented with ascites (60%), anorexia/weight loss (42%), vomiting (23%), diarrhea (9%) and tachypnea (9%), while subclinical infections (22%) were incidentally detected, typically during ovariohysterectomy or neuter. Survival at 6 months and 1 year post-diagnosis were 72.3% and 60.5%, respectively, and survival was not affected by sex or age. Using Cox proportional hazard analyses, we determined that the most significant factors influencing survival were the severity of clinical signs at the time of diagnosis and application of an aggressive treatment strategy after diagnosis. Dogs that were not treated aggressively were >5 times more likely to die than dogs that were treated with a combination of surgery/lavage and high doses of fenbendazole.
Subject(s)
Cestode Infections/veterinary , Dog Diseases/parasitology , Mesocestoides , Peritoneal Diseases/veterinary , Animals , Anthelmintics/therapeutic use , Cestode Infections/mortality , Cestode Infections/therapy , Dog Diseases/mortality , Dog Diseases/therapy , Dogs , Female , Fenbendazole/therapeutic use , Logistic Models , Male , Peritoneal Diseases/mortality , Peritoneal Diseases/parasitology , Peritoneal Diseases/therapy , Praziquantel/therapeutic use , Retrospective Studies , Survival AnalysisABSTRACT
Encapsulating peritoneal sclerosis (EPS) is a rare condition characterised by fibrotic thickening of the visceral peritoneum, leading to encapsulating of the intestines with partial or total intestinal obstruction. EPS is a serious complication of peritoneal dialysis (PD) with high morbidity and a mortality exceeding 50%. At present, there is uncertainty concerning the incidence and the risk factors involved in the development of EPS. To address these questions a nationwide registry has been initiated. The primary goals of the registry are to record the incidence of EPS and investigate the association of different variables, such as PD duration, medication, dialysis solutions and kidney transplantation with EPS. The registry will improve the knowledge of EPS and will serve to develop guidelines and necessary management strategies. From the registry different research activities can be initiated. A major challenge lies in the establishment of criteria that allow a timely diagnosis of EPS. At present, there are no diagnostic tools that can accurately detect EPS at an early stage. For this reason, besides patients with proven EPS, the clinical suspicion of EPS will be a sufficient criterion for inclusion in the registry. This nationwide EPS registry is currently enrolling patients.
Subject(s)
Evidence-Based Medicine , Health Knowledge, Attitudes, Practice , Peritoneal Diseases/epidemiology , Peritoneum/pathology , Registries , Access to Information , Data Collection , Humans , Incidence , Multivariate Analysis , Netherlands/epidemiology , Peritoneal Dialysis/adverse effects , Peritoneal Diseases/etiology , Peritoneal Diseases/mortality , Risk Factors , Sclerosis/pathologyABSTRACT
Encapsulating peritoneal sclerosis (EPS) is a rare complication in patients on peritoneal dialysis (PD), the prevalence of which increases with the time spent on PD. Various causative factors have been proposed, but the pathogenesis still remains unclear. The aim of our retrospective study was to analyze the basic clinical characteristics and outcomes of five patients diagnosed with EPS out of 423 patients treated with PD between January 1983 and December 2003. One patient was admitted due to ultrafiltration failure of the peritoneal membrane, and four patients were admitted for acute peritonitis. All of our patients presented with clinical symptoms suggestive of obstructive ileus. We confirmed the diagnosis of EPS with a computer tomography scan, a diagnostic laparotomy or laparoscopy, and a biopsy of the parietal peritoneum. We treated all of our patients with catheter removal, transferal to hemodialysis, antibiotics, complete parenteral nutrition, methylprednisolone, and tamoxifen for 6 months. One patient was treated with surgical enterolysis and died of septic complications, another patient died of sudden cardiac death during treatment. Three patients were doing well for 4-7 months after the treatment was started. The incidence of EPS was 1.2% and the mortality rate was 40%. EPS is a rare complication in longstanding PD patients in our institution. Despite treatment with hemodialysis, complete parenteral nutrition, steroids, tamoxifen and surgical intervention, the mortality rate is high and comparable to other reports.
Subject(s)
Peritoneal Dialysis/adverse effects , Peritoneal Diseases/etiology , Sclerosis/etiology , Adult , Female , Follow-Up Studies , Humans , Kidney Failure, Chronic/therapy , Male , Middle Aged , Peritoneal Diseases/mortality , Peritoneal Diseases/therapy , Peritoneum/pathology , Retrospective Studies , Sclerosis/mortality , Sclerosis/therapy , Slovenia/epidemiology , Young AdultABSTRACT
BACKGROUND AND OBJECTIVES: The study aim was to establish the incidence and characterize all encapsulating peritoneal sclerosis (EPS) cases in patients treated by peritoneal dialysis (PD). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The patient cohort, which started PD from January 1, 2000, to December 31, 2007, was identified from the Scottish Renal Registry (n = 1238). Possible EPS cases were identified by the ten adult Scottish renal units. Patient records were examined to ensure cases met diagnostic criteria. RESULTS: Forty-six cases were identified; 19 had their first PD exposure after January 1, 2000. The rate was 1.5%, an incidence of 4.9 per 1000 person-years. The incidence increased with PD duration, with rates of 0, 0.6, 2.0, 3.5, 8.1, 8.8 and 5% at <1, 1 to 2, >2 to 3, >3 to 4, >4 to 5, >5 to 6 and >6 yr PD exposure, respectively. The median PD duration of EPS cases was 5.1 yr (interquartile range [IQR] 3.4 to 6.1 yr). At diagnosis, 12 (26%) were on PD and 33 (72%) were diagnosed <2 yr after PD stopped. The cases had a median of 3.3 episodes of peritonitis (range 0 to 20, IQR 1 to 4.5). Thirty (65%) had used 3.86% dextrose dialysate and 45 (98%) had used Extraneal. The mortality was 42% at 1 yr postdiagnosis with a median survival of 149 d (IQR 61 to 408 d). CONCLUSIONS: The incidence reported in this study may be used to inform patients of the minimum risk of developing EPS on PD.
Subject(s)
Kidney Failure, Chronic/mortality , Kidney Failure, Chronic/therapy , Peritoneal Dialysis/adverse effects , Peritoneal Dialysis/mortality , Peritoneal Diseases/mortality , Adult , Aged , Aged, 80 and over , Bacterial Infections/mortality , Cohort Studies , Female , Humans , Incidence , Kaplan-Meier Estimate , Male , Middle Aged , Peritoneal Diseases/pathology , Registries , Risk Factors , Sclerosis , Scotland/epidemiology , Young AdultABSTRACT
BACKGROUND: Acute mesenteric obstruction (AMO) is usually fatal. This study was designed to demonstrate the demographic characteristics and prognostic factors of affected patients. METHODS: The patients admitted to our emergency department and diagnosed as having AMO between January 2000 and December 2004 were investigated retrospectively. Their demographic characteristics, laboratory results, per-operative findings and mortality were investigated retrospectively. RESULTS: Thirty patients (18 males, 12 females; mean age: 67 [26-92]) were evaluated. 43.3% of patients survived. Surviving patients had statistically significantly lower alanine aminotransferase (ALT) but also higher pH and creatinine levels (p=0.0027, 0.0004, 0.02). Colonic involvement also increased mortality (p<0.001). Papaverine infusion, embolectomy and second-look operations had no effect on outcome. CONCLUSION: Preoperatively increased liver enzymes, acidosis, and colonic involvement indicated poor prognosis. Papaverine infusion, embolectomy and second-look operations showed no advantages with respect to survival.
Subject(s)
Emergency Service, Hospital/statistics & numerical data , Mesentery , Peritoneal Diseases/mortality , Acidosis/complications , Acidosis/mortality , Adult , Aged , Aged, 80 and over , Colonic Diseases/complications , Colonic Diseases/mortality , Female , Humans , Liver/enzymology , Male , Middle Aged , Prognosis , Retrospective Studies , Survival AnalysisABSTRACT
Objetivo: Determinar los factores predisponentes para la formación de abscesos perirrenales y encontrar eventos asociados a una evolución desfavorable. Métodos: Realizamos un estudio clínico, descriptivo, retrospectivo y transversal que incluyó 23 pacientes con diagnóstico de absceso perirrenal ingresados en nuestro hospital. Resultados: Las entidades clinicas asociadas con el absceso perirrenal fueron: Diabetes mellitus en 65.2%, antecedente de litiasis renal en 43.47% y el antecedente de cirugia urologica en 17.38%. Al ingreso, la hemoglobina mayor a 10.5 g/dL y leucocitos menores a 15 x 103 / µL se asociaron con mayor frecuencia a nefrectomía y las plaquetas menores a 140 x 103 / µL se asociaron a choque séptico. La mortalidad general fue de 8.69% y 78.3% requirieron nefrectomía. Los pacientes que murieron presentaron al ingreso fiebre, anemia, leucocitosis mayor a 16 x 103 / µL, plaquetas menores a 130 x 103 / µL, sodio sérico menor a 125 mEq/L, requirieron nefrectomía y presentaron choque séptico. Conclusiones: En nuestra serie un buen porcentaje de pacientes con absceso perirrenal son portadores de diabetes mellitus y/o litiasis renal. El nivel de hemoglobina y de leucocitos se asoció con la pérdida de la unidad renal, la trombocitopenia se asoció a choque séptico y la hiponatremia con la mortalidad (AU)
Objectives: To determine predisposing factors in perinephric abscesses and to find events associated with unfavourable outcome. Methods: We carried out a clinical, descriptive, retrospective and cross-sectional study, including 23 patients diagnosed of perinephric abscess admitted to our hospital. Results: In patients with perinephric abscess, clinical charts included diabetes mellitus in 65.2%, history of nephrolithiasis in 43.47% and history of urological surgery in 17.38%. On hospital admission, haemoglobin greater than 10.5 g/dL and white blood cell count lower than 15 x 103 / µL were associated with nephrectomy, and platelet count lower than 140 x 103 / µL with septic shock. General mortality was 8.69%, and 78.3% if patient required nephrectomy. Patients who died had fever, anaemia, white blood cell count greater than 16 x 103 / µL, platelet count lower than 130 x 103 / µL, and hyponatremia of 125 mEq/L or lower at hospital admittance, and all of them had septic shock and required nephrectomy. Conclusions: In our series, a higher percentage of patients had diabetes mellitus and/or nephrolithiasis. Haemoglobin level and white blood cells count were associated with loss of the renal unit, thrombocytopenia was associated with septic shock and hyponatremia with mortality (AU)
Subject(s)
Adult , Humans , Abscess/mortality , Peritoneal Diseases/mortality , Abscess/etiology , Peritoneal Diseases/etiology , Causality , Retrospective Studies , Diabetes Mellitus/complications , Urinary Calculi/complications , Nephrectomy/methodsABSTRACT
Encapsulating peritoneal sclerosis is a rare, but potentially lethal, complication of peritoneal dialysis. Treatment of patients with encapsulating peritoneal sclerosis is controversial. Conservative treatment carries a poor outcome, and immunosuppressive drugs are now used frequently. Most commonly, these immunosuppressive regimens include steroids with or without azathioprine or cyclosporine. Mycophenolate mofetil is a reversible DNA synthesis inhibitor that frequently replaces azathioprine in renal transplantation because of its improved immunosuppressive potency and better side-effect profile. We report 3 cases of encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients for which an association of prednisone and mycophenolate mofetil significantly modified the evolution of the disease. All 3 patients showed significant improvement within a month and are still alive more than 2 years after the diagnosis of encapsulating peritoneal sclerosis. None experienced a relapse or abdominal symptoms, and body weights are stable. This is the first report of 3 cases of successful treatment of patients with encapsulating peritoneal sclerosis with prednisone and mycophenolate mofetil.
Subject(s)
Immunosuppressive Agents/therapeutic use , Intestine, Small/pathology , Mycophenolic Acid/analogs & derivatives , Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneal Diseases/drug therapy , Peritoneal Diseases/etiology , Peritoneum/pathology , Adult , Anti-Inflammatory Agents/therapeutic use , Ascites/etiology , Ascitic Fluid/microbiology , Candida glabrata/isolation & purification , Candidiasis/drug therapy , Candidiasis/etiology , Female , Fibrosis/complications , Fibrosis/drug therapy , Fibrosis/etiology , Humans , Intestinal Obstruction/etiology , Middle Aged , Mycophenolic Acid/therapeutic use , Peritoneal Diseases/mortality , Peritoneal Diseases/pathology , Peritonitis/drug therapy , Peritonitis/etiology , Prednisone/therapeutic use , Sclerosis/complications , Sclerosis/drug therapy , Sclerosis/etiology , Staphylococcus epidermidis/isolation & purificationABSTRACT
A three-year retrospective chart review was undertaken of all post-cardiothoracic ICU patients who underwent laparotomy for suspected mesenteric ischaemia, or who had the diagnosis confirmed at post mortem. The aim was to compare the clinical and diagnostic characteristics of cardiothoracic patients with suspected mesenteric ischaemia with patients who had a confirmed diagnosis. There were 3024 admissions to the cardiothoracic ICU over the three-year period. Twenty-six laparotomies were performed for suspected mesenteric ischaemia and 15 were positive for mesenteric ischaemia. The overall incidence of mesenteric ischaemia was 17/3024 (0.6%). Mortality for patients with mesenteric ischaemia was 13/17 (76%). Ischaemia was limited to a single segment of bowel in the four survivors. Mortality in patients who had a negative laparotomy for suspected mesenteric ischaemia was 7/11 (64%), attributable to cardiovascular failure (2/11) and multi-organ dysfunction syndrome (5/11). No clinical, biochemical or haematological test was discriminatory for mesenteric ischaemia. In patients with proven ischaemia, 7/13 plain abdominal radiographs were positive for ischaemia and 7/7 radiographs were negative for ischaemia in patients with no ischaemia (P = 0.05, PPV 1.0, NPV 0.5, sensitivity 54%, specificity 100%). Neither routine clinical investigations nor plain abdominal radiography reliably diagnose mesenteric ischaemia when the diagnosis is suspected clinically. Early laparotomy is recommended in these patients and further investigation may delay this procedure unnecessarily. The presence of mesenteric ischaemia identifies a cohort of patients with high mortality.
Subject(s)
Ischemia/mortality , Peritoneal Diseases/mortality , Postoperative Complications/mortality , Aged , Coronary Artery Bypass , Female , Humans , Ischemia/diagnosis , Ischemia/pathology , Laparotomy , Male , Peritoneal Diseases/diagnosis , Peritoneal Diseases/pathology , Postoperative Complications/diagnosis , Postoperative Complications/pathology , Retrospective Studies , Splanchnic CirculationABSTRACT
Between 1980 and 2002 a total of 187 patients (105 women, 82 men) with a mean age of 71.5 years underwent surgery for acute mesenteric infarction (AMI) in our department. Arterial occlusion was found in 140 patients, splanchnic vein thrombosis in 22, and nonocclusive AMI in 25. We performed bowel resection in 61 patients, vascular surgery in 32, a combination of the two in 15, and an exploratory laparotomy in 79. The mortality rate was 70.6% (73.9% in patients >70 years and 65.2% in those <70). AMI is still a disease with a consistently high mortality rate (60-80%). Multivariate prognostic factors include the time until surgery and a markedly elevated white blood cell count and serum lactate level. Mortality and secondary disease rates are higher in the elderly, and the fact that they have to wait much longer for an operation than younger patients may be a factor. If surgery is performed early, the survival rate increases regardless of age. The most important prognostic factor and the only one that can be influenced by the surgeon remains the time interval between the onset of symptoms and surgery, Therefore diagnostic and therapeutic intervention should be performed as early as possible in patients with suspected AMI.
Subject(s)
Infarction/surgery , Mesentery/blood supply , Peritoneal Diseases/surgery , Adult , Aged , Aged, 80 and over , Algorithms , Humans , Infarction/diagnosis , Infarction/mortality , Middle Aged , Multivariate Analysis , Peritoneal Diseases/diagnosis , Peritoneal Diseases/mortality , Prognosis , Splanchnic Circulation , Time FactorsABSTRACT
Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis program. It is characterised by high mortality. This article is a review of current knowledge concerning procedures in EPS. The views on change of renal replacement therapy--from peritoneal dialysis to hemodialysis were discussed. The possibilities of prevention and treatment of this complication were also presented.
Subject(s)
Peritoneal Dialysis, Continuous Ambulatory/adverse effects , Peritoneal Diseases/etiology , Peritoneum/pathology , Humans , Kidney Failure, Chronic/therapy , Peritoneal Diseases/mortality , Peritoneal Diseases/pathology , Renal Dialysis , Sclerosis/etiologyABSTRACT
OBJECTIVES: The purpose of the study was twofold: (1) to identify the incidence of acute mesenteric ischaemia (A.M.Isc.) following cardiopulmonary bypass and (2) to identify factors associated with its development. METHODS: A retrospective review of all autopsy reports from 1st January 1994 to 31st December 2000 was undertaken. Fifty-two patients were identified with acute mesenteric ischaemia at post-mortem following cardiac surgery. Demographic, pre-, intra- and post-operative variables were collected from their case notes. Four age, sex and period matched controls [n=208 (4 x 52)] were randomly selected for each case. Conditional logistic regression was used to compare the cases and controls. RESULTS: A total of 11,202 patients underwent surgery requiring cardiopulmonary bypass (CPB) during the study period with an overall mortality rate of 3%. The autopsy rate was 95% throughout the study period. From autopsy reports 52 patients (corrected for autopsy rate: 0.49% of group) were identified with A.M.Isc. Comparing controls with A.M.Isc. cases by univariate analysis, significant associations (P=0.001) with A.M.Isc. were identified. These included: (1) peripheral vascular disease [15 (7%) vs. 14 (27%)]; (2) intraaortic balloon pump (IABP) use [5 (2%) vs. 22 (42%)]; (3) post-operative renal failure [2 (1%) vs. 32 (61%)]; (4) operation type (coronary artery bypass graft (CABG) alone [143 (69%) vs. 25 (48%)], valve alone [35 (17%) vs. 5 (10%)], valve+CABG [23 (11%) vs. 11 (21%)], major cardiac [7 (3%) vs. 11 (21%)]); (5) priority of operation (elective [155 (75%) vs. 27 (52%) emergency 52 (25%) vs. 25 (48%)]; and (6) smoking 12 (7%) vs. 9 (17%). CPB and cross-clamp times (minutes) were also significantly different between the groups [median (inter-quartile range (IQR)); 72 (55,96) vs. 100 (76,128) and 39 (30,54) vs. 56 (37,84), respectively]. Neither diabetes 23 (11%) vs. 6 (12%) nor hypertension 102 (49%) vs. 26 (50%) achieved significance (P<0.001). CONCLUSION: The incidence of acute mesenteric ischaemia is 0.49% of all cases undergoing CPB. A.M.Isc. is a common association with death following CPB (11%). It appears to be significantly associated with the presence of peripheral vascular disease, IABP use, the development of post-operative renal failure, operation type and priority, smoking, duration of CPB and cross-clamp time. Surprisingly, it was not linked to general risk factors for vascular disease.
Subject(s)
Cardiopulmonary Bypass/adverse effects , Ischemia/mortality , Peritoneal Diseases/mortality , Postoperative Complications/mortality , Splanchnic Circulation , Acute Disease , Aged , Aged, 80 and over , Cardiopulmonary Bypass/methods , Cardiopulmonary Bypass/mortality , Case-Control Studies , Female , Humans , Intra-Aortic Balloon Pumping/adverse effects , Ischemia/etiology , Ligation , Logistic Models , Male , Mesentery , Middle Aged , Peripheral Vascular Diseases/complications , Renal Insufficiency/complications , Retrospective Studies , Smoking/adverse effects , Time FactorsABSTRACT
The purpose of this study was to assess the computed tomography (CT) and plain radiographic findings of acute mesenteric ischemia, in an effort to elucidate its poor prognostic signs. The study group consisted of 26 cases with pathologically or angiographically proven mesenteric ischemia. The pathologically proven longitudinal extent of the bowel ischemia was graded using six degrees, and correlated with the radiographic findings. The mortality of the patients depended primarily on the extent of infarctions and the age of the patient. Patients with bowel dilation or abnormal gas in the bowel wall or portal system were prone to have wider extents of ischemia.
Subject(s)
Ischemia/diagnostic imaging , Mesentery/blood supply , Radiography, Abdominal , Tomography, X-Ray Computed , Acute Disease , Adult , Aged , Aged, 80 and over , Female , Gases , Humans , Intestines/diagnostic imaging , Ischemia/etiology , Ischemia/mortality , Male , Mesenteric Veins/diagnostic imaging , Mesentery/diagnostic imaging , Middle Aged , Peritoneal Diseases/diagnostic imaging , Peritoneal Diseases/etiology , Peritoneal Diseases/mortality , Prognosis , Retrospective Studies , Severity of Illness Index , Survival RateABSTRACT
Virulence of herpes simplex virus (HSV) in mice has been demonstrated to be dependent on the site of infection. In this experiment, pathogenesis of HSV was studied in 2 different routes of infection in a mouse model system. When BALB/c mice were infected with 5 x 10(3) plaque-forming units (PFU) of virulent HSV type 1 Miyama GC+ strain (HSV-1-GC+) intraperitoneally, all mice were dead in 6 to 9 days. HSV-1-GC+ was recovered from organs such as the cerebrum, cerebellum, brainstem, and spleen 2 to 5 days after infection, but not from other organs such as trigeminal ganglia. However, if mice were infected in the maxillary gingiva with 1.0 x 10(7) PFU of HSV-1-GC+, all mice survived. HSV-1-GC+ was recovered from the trigeminal ganglia and brainstem 2 to 5 days after infection, but not from other organs tested. When mice were infected in maxillary gingiva with HSV-1-GC+, followed by the intraperitoneal injection of 6 mg of cyclophosphamide 72 hrs after virus infection, all mice were dead within days. Immunofluorescent and hematoxylin-eosin staining of gingival tissue sections revealed that when mice were infected in maxillary gingiva with HSV-1-GC+, 3 times as many gamma delta T-cells and 5 times as many polymorphonuclear cells can be detected in sections of maxillary gingiva when compared with non-infected mice. These data show that the gingiva of mice is considerably more resistant to infection with HSV, compared with the peritoneal cavity, and suggest the possible presence of an oral defense mechanism which might be different from that in the peritoneal cavity.
Subject(s)
Gingival Diseases/etiology , Herpes Simplex/etiology , Herpesvirus 1, Human/pathogenicity , Herpesvirus 2, Human/pathogenicity , Animals , Disease Models, Animal , Female , Gingiva/immunology , Gingiva/virology , Gingival Diseases/immunology , Gingival Diseases/mortality , Gingival Diseases/virology , Herpes Simplex/immunology , Herpes Simplex/mortality , Herpes Simplex/virology , Herpesvirus 1, Human/isolation & purification , Herpesvirus 2, Human/isolation & purification , Maxilla , Mice , Mice, Inbred AKR , Mice, Inbred BALB C , Mice, Inbred C3H , Peritoneal Cavity/virology , Peritoneal Diseases/etiology , Peritoneal Diseases/immunology , Peritoneal Diseases/mortality , Peritoneal Diseases/virology , Spleen/immunology , Spleen/virology , VirulenceABSTRACT
Fifty-eight children with isolated malrotation of the midgut were treated in our service between 1970 and 1993. They presented with acute bilious vomiting in 75% of cases. The remaining 25% consulted for various digestive symptoms. Diagnoses were established by an upper gastrointestinal radiographic study. Prognoses were good whenever an emergency operation was performed.
Subject(s)
Mesentery/abnormalities , Peritoneal Diseases/surgery , Barium Sulfate , Emergency Medicine , Enema , Female , Humans , Infant , Infant, Newborn , Male , Mesentery/diagnostic imaging , Mesentery/surgery , Peritoneal Diseases/complications , Peritoneal Diseases/diagnostic imaging , Peritoneal Diseases/mortality , Radiography , Retrospective Studies , Vomiting/etiologyABSTRACT
Intraperitoneal bleeding due to spontaneous rupture of hepatocellular carcinoma (HCC) is often a life-threatening condition as well as a poor prognostic sign in terms of the spread of neoplastic disease. Up to 12% of the patients with HCC are reported to develop this complication in Asia, while few cases have been observed to date in western countries, even in areas such as Italy where incidence of hepatocellular carcinoma is high. There is a lack of specific symptoms, therefore a correct diagnosis can be made only if the possibility of hepatocellular carcinoma rupture is taken into account in case of spontaneous hemoperitoneum and if imaging procedures are carefully focused on the liver. Once the presence of the malignant liver neoplasm is demonstrated, non surgical management, aimed solely at controlling the hemorrhage, can be considered. Herein we report 8 cases of spontaneous intraperitoneal bleeding observed in our Department. Our experience confirms that an exact diagnosis is rarely made before laparotomy and that long-term prognosis is poor even after surgical resection of the tumor: 5 of 7 patients who had hepatic resection developed an early recurrence and 4 of them died within one year.